Twice the output, half the runtime, and half the footprint of the UG 100® with greater flexibility and improved genomic coverage Introducing two new high-throughput instrument configurations ...
Zacks Investment Research on MSN
NTRA debuts Zenith Genomics next-gen sequencing test for rare diseases
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to ...
Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, today announced that Basecamp Research, a frontier AI lab for therapeutic design, has selected the UG200 Series as the ...
Tuberculosis (TB) is the world’s leading cause of death from a single infectious agent, affecting more than 10 million people ...
Safety and QoL considerations are reshaping sequencing, including avoidance of immunotherapy in certain drivers and adoption ...
Genomic sequencing has come a long way in a short time, and its potential to drive even faster innovations in precision medicine is enormous. To capitalize on that opportunity, however, health systems ...
Every year, millions of newborns undergo routine screening as a preventive strategy to detect inherited disorders before symptoms emerge. Newborn screening (NBS) programs have traditionally relied on ...
The field of thoracic oncology has undergone a significant transformation with the integration of next-generation genomic profiling technologies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results